Follow
Narendranath Epperla
Narendranath Epperla
Hematology and Oncology
Verified email at osumc.edu
Title
Cited by
Cited by
Year
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ...
Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021
862021
R‐CHOP versus dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis
NN Shah, A Szabo, SF Huntington, N Epperla, N Reddy, S Ganguly, ...
British journal of haematology 180 (4), 534-544, 2018
862018
Diffuse large B‐cell lymphoma with primary treatment failure: ultra‐high risk features and benchmarking for experimental therapies
LJ Costa, K Maddocks, N Epperla, NM Reddy, R Karmali, E Umyarova, ...
American journal of hematology 92 (2), 161-170, 2017
792017
Incidence, risk factors for and outcomes of transplant‐associated thrombotic microangiopathy
N Epperla, A Li, B Logan, C Fretham, S Chhabra, M Aljurf, L Chee, ...
British journal of haematology 189 (6), 1171-1181, 2020
722020
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study
N Epperla, M Hamadani, AF Cashen, KW Ahn, E Oak, AS Kanate, ...
Hematological oncology 35 (4), 528-535, 2017
672017
Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis
G Dang, N Epperla, V Muppidi, N Sahr, A Pan, P Simpson, LB Kreuziger
Asaio Journal 63 (4), 373-385, 2017
612017
Incidence and survival trends in mantle cell lymphoma.
N Epperla, M Hamadani, TS Fenske, LJ Costa
British Journal of Haematology 181 (5), 703-706, 2017
592017
Burkitt lymphoma international prognostic index
AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ...
Journal of clinical oncology 39 (10), 1129, 2021
552021
Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant
M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ...
JAMA oncology 7 (7), 993-1003, 2021
512021
Emerging therapies in mantle cell lymphoma
W Hanel, N Epperla
Journal of hematology & oncology 13, 1-18, 2020
502020
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy
IB Greenwell, AD Staton, MJ Lee, JM Switchenko, DF Saxe, JJ Maly, ...
Cancer 124 (11), 2306-2315, 2018
502018
Blessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia
N Epperla, W Hocking
Clinical Medicine & Research 13 (1), 32-35, 2015
432015
Association of reduced-intensity conditioning regimens with overall survival among patients with non-Hodgkin lymphoma undergoing allogeneic transplant
N Ghosh, S Ahmed, KW Ahn, M Khanal, C Litovich, M Aljurf, VU Bacher, ...
JAMA oncology 6 (7), 1011-1018, 2020
422020
Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: current controversies and advances
N Epperla, M Hamadani
Hematology/oncology and stem cell therapy 10 (4), 277-284, 2017
402017
Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone
N Epperla, F McKiernan
Springerplus 4, 1-7, 2015
392015
Sjögren’s syndrome and neuromyelitis optica spectrum disorders (NMOSD)-a case report and review of literature
A Jayarangaiah, R Sehgal, N Epperla
BMC neurology 14, 1-6, 2014
392014
Association between blood glucose level and outcomes in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease
Y Kasirye, M Simpson, CK Mamillapalli, N Epperla, H Liang, SH Yale
Wmj 112 (6), 244-9, 2013
352013
Phase I trial of N-803, an IL15 receptor agonist, with rituximab in patients with indolent non-Hodgkin lymphoma
JA Foltz, BT Hess, V Bachanova, NL Bartlett, MM Berrien-Elliott, ...
Clinical Cancer Research 27 (12), 3339-3350, 2021
342021
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
NN Shah, KW Ahn, C Litovich, TS Fenske, S Ahmed, M Battiwalla, ...
Blood advances 2 (8), 933-940, 2018
342018
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma …
N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ...
Journal of Hematology & Oncology 12, 1-11, 2019
332019
The system can't perform the operation now. Try again later.
Articles 1–20